Abstract     Description     Claims     Drawing  

WO0168109A1   [0012] 
EP1282438B1   [0013] 
EP1282439B1   [0013] 
WO0240544A2   [0014] 
WO2008092644A   [0096]  [0097] 
WO2008092643A   [0096]  [0097] 

Biochemistry   [0153]  [0162] 
Blood   [0162] 
THE JOURNAL OF BIOLOGICAL CHEMISTRY   [0162] 
THE JOURNAL OF BIOLOGICAL CHEMISTRY   [0162] 
Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo   [0162] 
Biochemistry   [0162] 
Biochemistry   [0162] 
Activation of human factor IX (Christmas factor)   [0162] 
Intrinsic pathway activation of factor X and its activation peptide-deficient derivative, factor Xdes-143-191   [0162] 
Biochemistry   [0162] 
The molecular basis of blood coagulation   [0162] 
Nucleic Acids Res.   [0162] 
Blood (ASH Annual Meeting Abstracts)   [0162] 
J Biol Chem.   [0162] 
EMBO J.   [0162] 
PNAS   [0162] 
Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure   [0162] 
J. Biol. Chem.   [0162] 
Arterioscler Thromb Vasc Biol   [0162] 
Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates   [0162] 
Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro   [0162] 
Blood   [0162] 
Non-viral gene transfer results in therapeutic factor IX levels in haemophilia B mice   [0162] 
Physiological fIXa activation involves a cooperative conformational rearrangement of the 99-loop   [0162] 
MOLECULAR THERAPY   [0162]